NCT01525550 2019-07-30A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsPfizerPhase 4 Completed106 enrolled 26 charts
NCT00428597 2010-10-11A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell TumorsPfizerPhase 3 Terminated171 enrolled 28 charts